The Cost performance category replaced the Value-Based Modifier (VBM). The cost of the care provided is calculated by CMS, based on the clincian’s Medicare claims. MIPS uses cost measures to gauge the total cost of care during the year or during a hospital stay. In 2021, this performance category counts toward the final MIPS score.
For 2021, the Cost category makes up 20% of a provider’s final score.
Providers are evaluated, in the Cost category, based on their Medicare claims data. Thus, there are no data submission or reporting requirements.
Providers are scored by comparing their performance against annual benchmarks, created by CMS. For 2021, cost measures are used to assess the beneficiary’s total cost of care during the year, or during a hospital stay, and/or 18 episodes of care.
The Elective Outpatient PCI cost measure is meant to apply to clinicians who perform Elective Outpatient PCIs for Medicare beneficiaries during the performance period. This surgical procedure is meant to place a coronary artery stent for heart disease in a non-emergent, outpatient setting. The measure evaluates a clinician’s risk-adjusted cost for the episode group by averaging it across all episodes attributed to the clinician. The cost of each episode is the sum of the cost to Medicare for services performed by the attributed clinician and other health care providers over the length of the episode, or “episode window.” The cost measure is calculated by determining the risk-adjusted episode cost, averaged across all of a clinician’s episodes during the performance period.
COST_EOPCI_1
Administrative Claims
The Intracranial Hemorrhage or Cerebral Infarction cost measure is meant to apply to clinicians who manage the inpatient care of Medicare beneficiaries hospitalized for an intracranial hemorrhage or cerebral infarction during the performance period. This cost measure excludes those patients whose initial hospitalization was due to a subarachnoid hemorrhage or a cerebral infarction which received thrombolytic therapy. The measure evaluates a clinician’s risk-adjusted cost for the episode group by averaging it across all episodes attributed to the clinician. The cost of each episode is the sum of the cost to Medicare for services performed by the attributed clinician and other health care providers over the length of the episode, or “episode window.” The cost measure is calculated by determining the risk-adjusted episode cost, averaged across all of a clinician’s episodes during the performance period.
COST_IHCI_1
Administrative Claims
The Knee Arthroplasty cost measure is meant to apply to clinicians who perform elective total and partial knee arthroplasties during the performance period for Medicare beneficiaries. This surgical procedure is meant to replace a patient’s own poorly functional knee with an artificial one, thereby reducing pain and increasing mobility. The measure evaluates a clinician’s risk-adjusted cost for the episode group by averaging it across all episodes attributed to the clinician. The cost of each episode is the sum of the cost to Medicare for services performed by the attributed clinician and other health care providers over the length of the episode, or “episode window.” The cost measure is calculated by determining the risk-adjusted episode cost, averaged across all of a clinician’s episodes during the performance period.
COST_KA_1
Administrative Claims
The Medicare Spending Per Beneficiary (MSPB) measure evaluates solo practitioners and groups on their spending efficiency and is risk-adjusted to account for patients’ risk profiles. Solo practitioners and groups are identified by their National Provider Identification (NPI) and Taxpayer Identification Number (TIN) combination. Specifically, the MSPB measure assesses the average spend for Medicare services performed by providers/groups per episode of care. Each episode comprises the period immediately prior to, during, and following a patient’s hospital stay.
MSPB_1
Administrative Claims
The Revascularization for Lower Extremity Chronic Critical Limb Ischemia cost measure is meant to apply to clinicians who perform elective revascularization for lower extremity chronic critical limb ischemia for Medicare beneficiaries during the performance period. This surgical procedure is meant to alleviate symptoms of pain and difficulty walking associated with chronic limb ischemia and excludes those patients who require emergent revascularization for acute limb ischemia. The measure evaluates a clinician’s risk-adjusted cost for the episode group by averaging it across all episodes attributed to the clinician. The cost of each episode is the sum of the cost to Medicare for services performed by the attributed clinician and other health care providers over the length of the episode, or “episode window.” The cost measure is calculated by determining the risk-adjusted episode cost, averaged across all of a clinician’s episodes during the performance period.
COST_CCLI_1
Administrative Claims
The Routine Cataract Removal with IOL Implantation cost measure is meant to apply to clinicians who perform Routine Cataract Removal with IOL Implantation procedures for Medicare beneficiaries during the performance period. The measure evaluates a clinician’s risk-adjusted cost for the episode group by averaging it across all episodes attributed to the clinician. The cost of each episode is the sum of the cost to Medicare for services performed by the attributed clinician and other health care providers over the length of the episode, or “episode window.” The cost measure is calculated by determining the risk-adjusted episode cost, averaged across all of a clinician’s episodes during the performance period.
COST_IOL_1
Administrative Claims
The Screening/Surveillance Colonoscopy cost measure is meant to apply to clinicians who perform screening/surveillance colonoscopy procedures for Medicare beneficiaries during the performance period. Screening and surveillance colonoscopies are preventative care procedures that are meant to detect the presence of colorectal cancer (CRC) among patients who are at average risk or high risk of CRC, respectively. The measure evaluates a clinician’s risk-adjusted cost for the episode group by averaging it across all episodes attributed to the clinician. The cost of each episode is the sum of the cost to Medicare for services performed by the attributed clinician and other health care providers over the length of the episode, or “episode window.” The cost measure is calculated by determining the risk-adjusted episode cost, averaged across all of a clinician’s episodes during the performance period.
COST_SSC_1
Administrative Claims
The Simple Pneumonia with Hospitalization cost measure is meant to apply to clinicians who manage the inpatient care of Medicare beneficiaries hospitalized with simple pneumonia during the performance period. This acute inpatient medical condition episode group is meant to capture patients who are hospitalized for pneumonia without severe complicating factors. The measure evaluates a clinician’s risk-adjusted cost for the episode group by averaging it across all episodes attributed to the clinician. The cost of each episode is the sum of the cost to Medicare for services performed by the attributed clinician and other health care providers over the length of the episode, or “episode window.” The cost measure is calculated by determining the risk-adjusted episode cost, averaged across all of a clinician’s episodes during the performance period.
COST_SPH_1
Administrative Claims
The STEMI with PCI cost measure is meant to apply to clinicians who manage the inpatient care of Medicare beneficiaries hospitalized during the performance period for a STEMI requiring PCI. This acute medical condition captures the care of those patients who present with STEMI indicating complete blockage of a coronary artery who emergently receive PCI as treatment. The measure evaluates a clinician’s risk-adjusted cost for the episode group by averaging it across all episodes attributed to the clinician. The cost of each episode is the sum of the cost to Medicare for services performed by the attributed clinician and other health care providers over the length of the episode, or “episode window.” The cost measure is calculated by determining the risk-adjusted episode cost, averaged across all of a clinician’s episodes during the performance period.
COST_STEMI_1
Administrative Claims
The Total Per Capita Costs (TPCC) measure is a payment-standardized, annualized, risk-adjusted, and specialty-adjusted measure that evaluates the overall efficiency of care provided to beneficiaries attributed to solo practitioners and groups, as identified by their Medicare Taxpayer Identification Number (TIN).
TPCC_1
Administrative Claims